Delivery Order SPE2DB22D3004-SPE2DB23FRE93
Award Date 9/6/23
Potential Completion Date 9/7/23
Potential Value $1.5K
Federal Agency
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- Amerisourcebergen Drug Corporation, a division of Amerisourcebergen Corporation, has been awarded a delivery order valued at two thousand eight hundred twelve dollars and sixty-nine cents ($2,812.69) by the Defense Logistics Agency of the Department of Defense. The firm fixed price order is for one hundred (100) tablets of thirty-six (36) milligram methylphenidate ER, to be delivered to a location in Conshohocken, Pennsylvania. Performance will take place between August 23 and August 24 of 2023....
- Amerisourcebergen Drug Corporation, a division of Amerisourcebergen Corporation, has been awarded a delivery order valued at $3,028.69 by the Defense Logistics Agency (DLA) to provide one hundred tablets of 36mg methylphenidate extended release under firm fixed price terms. Performance will take place at Amerisourcebergen's facility in Conshohocken, Pennsylvania, spanning from August 15 to August 16, 2023. The prime contractor will deliver the requested pharmaceutical products to the DLA, the...
- Amerisourcebergen Drug Corporation, operating as a division of Amerisourcebergen Corporation, has been awarded a firm fixed price delivery order valued at one thousand four hundred fifty-three dollars and ninety cents ($1,453.90) to supply the Defense Logistics Agency Troop Support Medical with ninety (90) tablets of the eighteen (18) milligram extended release formulation of methylphenidate. Performance will take place at Amerisourcebergen's facility in Conshohocken, Pennsylvania, with delivery...
- Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, has received a $3,106.71 firm fixed price delivery order from the Defense Logistics Agency (DLA) Troop Support Medical to supply 100 tablets of 27 mg methylphenidate extended release under delivery order number 4562645500. Performance will take place at Amerisourcebergen's headquarters in Conshohocken, Pennsylvania by October 31, 2023. No set-aside designation was applied to this order, which was awarded off an...
- Amerisourcebergen Drug Corporation, a division of Amerisourcebergen Corporation, has been awarded a delivery order valued at approximately $1,255 by the Defense Logistics Agency to provide 90 tablets of 27mg methylphenidate extended release for placement at a facility located in Conshohocken, Pennsylvania. The firm fixed price order is associated with DLA's pharmaceutical distribution program and has a period of performance from September 27-28, 2023. No set aside designation or subcontractors...
- Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, has received a $3,028 firm fixed price delivery order from the Defense Logistics Agency (DLA) Troop Support Medical to supply 100 tablets of 54mg methylphenidate extended release. Performance will take place at Amerisourcebergen's headquarters in Conshohocken, Pennsylvania, with completion by November 28, 2023. No set-aside designation was applied to this order, which was awarded under an existing DLA vehicle to...
- Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, has received a $1,718 firm fixed price delivery order from the Defense Logistics Agency (DLA) Troop Support Medical to supply 100 units of 36mg methylphenidate extended release tablets. Performance will take place at Amerisourcebergen's headquarters in Conshohocken, Pennsylvania by December 7, 2023. No set aside designation was applied to this order placed under an existing DLA medical supply contract vehicle....
- Amerisourcebergen Drug Corp has received a firm fixed price delivery order for $1,963.06 from the Defense Logistics Agency (DLA) Troop Support Medical to supply 100 tablets of 36mg methylphenidate extended release under an indefinite delivery contract. Performance will take place at Amerisourcebergen's headquarters in Conshohocken, Pennsylvania, with completion by October 27, 2023. No set-aside designation was applied to this award to supply pharmaceutical products in support of DLA medical...
- Amerisourcebergen Drug Corporation, a subsidiary of Amerisourcebergen Corporation, has been awarded a firm fixed price delivery order valued at two thousand five hundred eighty-two dollars and seventy-five cents ($2,582.75) by the Defense Logistics Agency Troop Support Medical to supply one hundred (100) tablets of thirty-six (36) milligram methylphenidate extended release. Performance will take place in Conshohocken, Pennsylvania under a start date of August 7, 2023 and end date of August 8,...
- Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, has received a $4,458.48 firm fixed price delivery order from the Defense Logistics Agency (DLA) Troop Support Medical to supply 100 units of 27mg methylphenidate extended release tablets. Performance will take place at Amerisourcebergen's headquarters in Conshohocken, Pennsylvania by December 7, 2023. No set-aside designation was applied to this order, which was awarded under an existing indefinite-delivery contract...
- SPE2DB22D3004Indefinite Delivery Contract
- SPE2DB22D3004-SPE2DB23FRE93Delivery Order
Amerisourcebergen Drug Corporation, a division of Amerisourcebergen Corporation, has been awarded a delivery order valued at one thousand four hundred fifty dollars and ninety-six cents ($1,450.96) by the Defense Logistics Agency (DLA) to provide one hundred (100) tablets of thirty-six (36) milligram methylphenidate extended release for performance at its facility in Conshohocken, Pennsylvania. The firm fixed price order is associated with DLA's pharmaceutical procurement program and has a period of performance from September 6, 2023 through September 7, 2023. No subcontractors or set aside designations were identified.
Generated 12/22/23, 10:59 PM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.5k | 9/6/23 |